Anticancer agent 87
Anticancer agent 87 is a spirooxindole-furan derivative with anticancer activity. Anticancer agent 87 can be used for the research of breast adenocarcinoma and human liver cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C30H21BrCl2N2O3S
- Masse moléculaire:640.37
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
Anticancer agent 87 (Compound 6f) potently inhibits the viability of MCF7 breast adenocarcinoma cells with an IC50 of 10.3 μM/mL[1].
Anticancer agent 87 potently inhibits the viability of HepG2 liver carcinoma cells with an IC50 of 3.5 μM/mL[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Masse moléculaire 640.37
-
Formule C30H21BrCl2N2O3S
-
SMILES
O=C1NC2=C(C=CC(Cl)=C2)[C@@]13N4CSCC4[C@@H](C5=CC=C(C6=CC=CC=C6Cl)O5)[C@@H]3C(C7=CC=C(Br)C=C7)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)